{"id":"https://openalex.org/W4398200735","doi":"https://doi.org/10.1016/j.ejps.2024.106808","title":"Dose finding for ZSP1601 in patients with nonalcoholic steatohepatitis using population pharmacokinetics and exposure\u2013response approach","display_name":"Dose finding for ZSP1601 in patients with nonalcoholic steatohepatitis using population pharmacokinetics and exposure\u2013response approach","publication_year":2024,"publication_date":"2024-05-22","ids":{"openalex":"https://openalex.org/W4398200735","doi":"https://doi.org/10.1016/j.ejps.2024.106808","pmid":"https://pubmed.ncbi.nlm.nih.gov/38788909"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejps.2024.106808","doi":"https://doi.org/10.1016/j.ejps.2024.106808","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejps.2024.106808","pdf_url":null,"source":{"id":"https://openalex.org/S119477091","display_name":"European Journal of Pharmaceutical Sciences","issn_l":"0928-0987","issn":["0928-0987","1879-0720"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.ejps.2024.106808","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5107889467","display_name":"Haijun Li","orcid":"https://orcid.org/0009-0002-9143-6653","observed_orcids":["https://orcid.org/0009-0002-9143-6653"]},"institutions":[{"id":"https://openalex.org/I139660479","display_name":"Central South University","ror":"https://ror.org/00f1zfq44","country_code":"CN","type":"education","lineage":["https://openalex.org/I139660479"]},{"id":"https://openalex.org/I4405267154","display_name":"Guangdong Raynovent Biotech Co., Ltd. (China)","ror":"https://ror.org/01e43vr22","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267154"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Haijun Li","raw_affiliation_strings":["Department of Anatomy and Neurobiology, School of Basic Medical Science, Central South University, Changsha, China; Guangdong Raynovent Biotech Co., Ltd, Guangzhou, China","Department of Anatomy and Neurobiology, School of Basic Medical Science, Central South University, Changsha, China","Guangdong Raynovent Biotech Co., Ltd, Guangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Anatomy and Neurobiology, School of Basic Medical Science, Central South University, Changsha, China; Guangdong Raynovent Biotech Co., Ltd, Guangzhou, China","institution_ids":["https://openalex.org/I139660479","https://openalex.org/I4405267154"]},{"raw_affiliation_string":"Department of Anatomy and Neurobiology, School of Basic Medical Science, Central South University, Changsha, China","institution_ids":["https://openalex.org/I139660479"]},{"raw_affiliation_string":"Guangdong Raynovent Biotech Co., Ltd, Guangzhou, China","institution_ids":["https://openalex.org/I4405267154"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100626598","display_name":"Yue Hu","orcid":"https://orcid.org/0000-0001-5346-0164","observed_orcids":["https://orcid.org/0000-0001-5346-0164"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yue Hu","raw_affiliation_strings":["Phase I Clinical Research Center, The First Hospital of Jilin University, Changchun, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phase I Clinical Research Center, The First Hospital of Jilin University, Changchun, China","institution_ids":["https://openalex.org/I4210125137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101703827","display_name":"Yuting Yang","orcid":"https://orcid.org/0000-0002-3245-4176","observed_orcids":["https://orcid.org/0000-0002-3245-4176"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuting Yang","raw_affiliation_strings":["Shanghai Qiangshi Information Technology Co., Ltd., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai Qiangshi Information Technology Co., Ltd., Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101230733","display_name":"Fengyan Xu","orcid":"https://orcid.org/0009-0005-9037-1765","observed_orcids":["https://orcid.org/0009-0005-9037-1765"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fengyan Xu","raw_affiliation_strings":["Shanghai Qiangshi Information Technology Co., Ltd., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai Qiangshi Information Technology Co., Ltd., Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101466777","display_name":"Zhongyi Sun","orcid":"https://orcid.org/0009-0003-7249-5428","observed_orcids":["https://orcid.org/0009-0003-7249-5428"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhongyi Sun","raw_affiliation_strings":["Shanghai Qiangshi Information Technology Co., Ltd., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai Qiangshi Information Technology Co., Ltd., Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063673617","display_name":"Jufang Huang","orcid":"https://orcid.org/0000-0002-9161-1055","observed_orcids":["https://orcid.org/0000-0002-9161-1055"]},"institutions":[{"id":"https://openalex.org/I139660479","display_name":"Central South University","ror":"https://ror.org/00f1zfq44","country_code":"CN","type":"education","lineage":["https://openalex.org/I139660479"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jufang Huang","raw_affiliation_strings":["Department of Anatomy and Neurobiology, School of Basic Medical Science, Central South University, Changsha, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Anatomy and Neurobiology, School of Basic Medical Science, Central South University, Changsha, China","institution_ids":["https://openalex.org/I139660479"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100366720","display_name":"Kun Wang","orcid":"https://orcid.org/0000-0003-2609-6058","observed_orcids":["https://orcid.org/0000-0003-2609-6058","https://orcid.org/0000-0003-4341-0248"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Kun Wang","raw_affiliation_strings":["Shanghai Qiangshi Information Technology Co., Ltd., Shanghai, China. Electronic address: kun.wang@shcscc.com","Shanghai Qiangshi Information Technology Co., Ltd., Shanghai, China"],"raw_orcid":"https://orcid.org/0000-0003-2609-6058","affiliations":[{"raw_affiliation_string":"Shanghai Qiangshi Information Technology Co., Ltd., Shanghai, China. Electronic address: kun.wang@shcscc.com","institution_ids":[]},{"raw_affiliation_string":"Shanghai Qiangshi Information Technology Co., Ltd., Shanghai, China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5104668789","display_name":"Xiaoxin Chen","orcid":"https://orcid.org/0000-0002-1617-3315","observed_orcids":["https://orcid.org/0000-0002-1617-3315"]},"institutions":[{"id":"https://openalex.org/I4405267154","display_name":"Guangdong Raynovent Biotech Co., Ltd. (China)","ror":"https://ror.org/01e43vr22","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267154"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Xiaoxin Chen","raw_affiliation_strings":["Guangdong Raynovent Biotech Co., Ltd, Guangzhou, China. Electronic address: chen_xiaoxin@raynovent.com","Guangdong Raynovent Biotech Co., Ltd, Guangzhou, China"],"raw_orcid":"https://orcid.org/0000-0002-1617-3315","affiliations":[{"raw_affiliation_string":"Guangdong Raynovent Biotech Co., Ltd, Guangzhou, China. Electronic address: chen_xiaoxin@raynovent.com","institution_ids":["https://openalex.org/I4405267154"]},{"raw_affiliation_string":"Guangdong Raynovent Biotech Co., Ltd, Guangzhou, China","institution_ids":["https://openalex.org/I4405267154"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5100366720","https://openalex.org/A5104668789"],"corresponding_institution_ids":["https://openalex.org/I4405267154"],"apc_list":{"value":2700,"currency":"USD","value_usd":2700},"apc_paid":{"value":2700,"currency":"USD","value_usd":2700},"fwci":2.2875,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.85875361,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"199","issue":null,"first_page":"106808","last_page":"106808"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.7289999723434448,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.7289999723434448,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.09889999777078629,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.061500001698732376,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-alcoholic-steatohepatitis","display_name":"nonalcoholic steatohepatitis","score":0.9169999957084656},{"id":"https://openalex.org/keywords/non-alcoholic-fatty-liver-disease","display_name":"non-alcoholic fatty liver disease","score":0.9700000286102295},{"id":"https://openalex.org/keywords/phosphodiesterase-inhibitors","display_name":"phosphodiesterase inhibitors","score":0.7990000247955322},{"id":"https://openalex.org/keywords/dose-finding","display_name":"dose-finding","score":0.8550000190734863},{"id":"https://openalex.org/keywords/population-pharmacokinetics","display_name":"population pharmacokinetics","score":0.9409999847412109},{"id":"https://openalex.org/keywords/exposure-response-relationship","display_name":"exposure-response relationship","score":0.9070000052452087},{"id":"https://openalex.org/keywords/dose-selection","display_name":"dose selection","score":0.42399999499320984},{"id":"https://openalex.org/keywords/food-effects-on-drug-absorption","display_name":"food effect on absorption","score":0.5820000171661377},{"id":"https://openalex.org/keywords/body-weight-effects","display_name":"body weight effects","score":0.6140000224113464},{"id":"https://openalex.org/keywords/alanine-aminotransferase","display_name":"alanine aminotransferase","score":0.9169999957084656},{"id":"https://openalex.org/keywords/aspartate-aminotransferase","display_name":"aspartate aminotransferase","score":0.9909999966621399},{"id":"https://openalex.org/keywords/liver-fat-content","display_name":"liver fat","score":0.9879999756813049},{"id":"https://openalex.org/keywords/headache-adverse-event","display_name":"headache adverse event","score":0.6759999990463257},{"id":"https://openalex.org/keywords/two-compartment-model","display_name":"two-compartment model","score":0.6990000009536743}],"concepts":[{"id":"https://openalex.org/C3018708256","wikidata":"https://www.wikidata.org/wiki/Q1546498","display_name":"Nonalcoholic steatohepatitis","level":5,"score":0.9419399499893188},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7685424089431763},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5752928256988525},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.452382355928421},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37608546018600464},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3507566452026367},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.21099209785461426},{"id":"https://openalex.org/C2776954865","wikidata":"https://www.wikidata.org/wiki/Q1546498","display_name":"Nonalcoholic fatty liver disease","level":4,"score":0.19500911235809326},{"id":"https://openalex.org/C2778772119","wikidata":"https://www.wikidata.org/wiki/Q6058862","display_name":"Fatty liver","level":3,"score":0.06676477193832397},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010726","descriptor_name":"Phosphodiesterase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010726","descriptor_name":"Phosphodiesterase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065626","descriptor_name":"Non-alcoholic Fatty Liver Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ejps.2024.106808","doi":"https://doi.org/10.1016/j.ejps.2024.106808","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejps.2024.106808","pdf_url":null,"source":{"id":"https://openalex.org/S119477091","display_name":"European Journal of Pharmaceutical Sciences","issn_l":"0928-0987","issn":["0928-0987","1879-0720"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmid:38788909","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38788909","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.ejps.2024.106808","doi":"https://doi.org/10.1016/j.ejps.2024.106808","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejps.2024.106808","pdf_url":null,"source":{"id":"https://openalex.org/S119477091","display_name":"European Journal of Pharmaceutical Sciences","issn_l":"0928-0987","issn":["0928-0987","1879-0720"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1965479467","https://openalex.org/W1973097930","https://openalex.org/W1993147091","https://openalex.org/W1996415443","https://openalex.org/W2019317175","https://openalex.org/W2042553471","https://openalex.org/W2065039877","https://openalex.org/W2204688218","https://openalex.org/W3021816438","https://openalex.org/W3134567410","https://openalex.org/W3174706984","https://openalex.org/W4225965275","https://openalex.org/W4311455437","https://openalex.org/W4323670059","https://openalex.org/W4361281698","https://openalex.org/W4387569597"],"related_works":["https://openalex.org/W4387569597","https://openalex.org/W3134567410","https://openalex.org/W4240425535","https://openalex.org/W4386594281","https://openalex.org/W4404540599","https://openalex.org/W4391771311","https://openalex.org/W4223991389","https://openalex.org/W3037875011","https://openalex.org/W4378071126","https://openalex.org/W2799619756"],"abstract_inverted_index":{"ZSP1601":[0,31,52,110,115,122,197,205],"is":[1,21,67,285],"a":[2,24,103,153,210],"novel":[3],"pan-phosphodiesterase":[4],"inhibitor":[5],"developed":[6],"in":[7,74],"China":[8],"specifically":[9],"for":[10,30,179,243,268,287],"the":[11,47,75,202,244,257,276],"treatment":[12],"of":[13,46,78,82,260,273,279],"nonalcoholic":[14],"fatty":[15],"liver":[16],"disease":[17],"(NAFLD).":[18],"The":[19,65,171,219,249],"aim":[20],"to":[22,42,61,68,108,194],"develop":[23],"population":[25],"pharmacokinetic":[26,145],"(pop":[27],"PK)":[28],"model":[29,132,174,221],"by":[32],"integrating":[33],"data":[34,85],"from":[35,86,92],"two":[36,93],"clinical":[37,48,79,94,289],"studies.":[38],"This":[39],"undertaking":[40],"aims":[41],"deepen":[43],"our":[44],"understanding":[45],"factors":[49],"that":[50],"influence":[51],"exposure":[53,198,206],"while":[54,161],"simultaneously":[55],"investigating":[56],"exposure\u2013response":[57,177,212],"(ER)":[58,251],"relationships":[59,120,178],"related":[60],"efficacy":[62,124,235,261],"and":[63,99,119,125,139,169,186,196,222,234,262],"safety.":[64],"goal":[66],"guide":[69],"formulating":[70],"optimal":[71,258],"dosage":[72,241,266],"strategies":[73],"subsequent":[76,288],"phases":[77],"trials.":[80],"Analysis":[81],"pooled":[83],"concentration\u2013time":[84],"95":[87],"subjects,":[88],"with":[89,214],"2647":[90],"observations":[91],"trials":[95],"involving":[96],"healthy":[97],"volunteers":[98],"NAFLD":[100],"patients,":[101],"employed":[102],"nonlinear":[104],"mixed-effects":[105],"modeling":[106],"approach":[107],"characterize":[109],"pharmacokinetics.":[111],"Covariate":[112,147],"impact":[113],"on":[114,201,226],"pharmacokinetics":[116],"was":[117],"investigated,":[118],"between":[121],"exposure,":[123],"safety":[126,233,263],"endpoints":[127],"were":[128],"explored.":[129],"A":[130],"two-compartment":[131],"featuring":[133],"sequential":[134],"zero-order":[135],"then":[136],"first-order":[137,140],"absorption":[138,166],"elimination":[141],"effectively":[142],"described":[143],"ZSP1601\u2032s":[144,231],"profile.":[146],"analyses":[148],"identified":[149],"body":[150],"weight":[151],"as":[152],"statistically":[154],"significant":[155,211],"factor":[156],"affecting":[157],"drug":[158],"central":[159],"volume,":[160],"FED":[162],"(food":[163],"consumption)":[164],"influenced":[165],"rate":[167],"constant":[168],"duration.":[170],"Sigmoidal":[172],"Emax":[173],"aptly":[175],"captured":[176],"ALT":[180],"(alanine":[181],"aminotransferase),":[182,185],"AST":[183],"(aspartate":[184],"LFC":[187],"(liver":[188],"fat":[189],"content)":[190],"percentage":[191],"changes":[192],"relative":[193],"baseline":[195],"levels":[199,207],"(AUCss)":[200],"29th":[203],"day.":[204],"(Cmax1)":[208],"exhibited":[209],"relationship":[213],"headaches":[215],"(p":[216],"<":[217],"0.001).":[218],"PopPK":[220],"ER":[223],"analysis,":[224],"based":[225],"available":[227],"data,":[228],"comprehensively":[229],"characterizes":[230],"pharmacokinetic,":[232],"profile,":[236],"aiding":[237],"informed":[238],"decisions":[239],"regarding":[240],"selection":[242],"drug's":[245],"complete":[246],"developmental":[247],"trajectory.":[248],"exposure-response":[250],"analysis":[252],"yields":[253],"quantitative":[254],"insights":[255],"into":[256],"balance":[259],"within":[264],"different":[265],"regimens":[267],"patient":[269],"administration.":[270],"In":[271],"light":[272],"these":[274],"findings,":[275],"dose":[277],"regimen":[278],"100":[280],"mg":[281],"administered":[282],"twice":[283],"daily":[284],"proposed":[286],"investigations.":[290]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2024-05-23T00:00:00"}